The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Good find Brand more confounding factors to be investigated in immunology
Https://www.bbc.co.uk/news/technology-66394406
loadsoflolly
I posted this over a month ago and Lemos is mentioned Also in another earlier report Jeremy Hunt talks of creating a UK Silicon Valley It all sound hopeful But there are lots of buts
ATB
Thanks @nothopeful
Good explanation
I have added this for to stress the importance
https://academicentrepreneurship.pubpub.org/pub/1fani3y6/release/3
I have been in this share the late 1990's when they started up in Newport and Arm holdings excited the chip industry .Yes there have been many false dawns for sure but just hoping with the new CEO ,new innovation and a new technological era
Lord loadsoflolly
Nothing wrong in being cautious and making evidence based decisions But you would think that IQE involvement in supplying tech for autonomous vehicles and now AI etc would benefit sentiment and attract institutional investors and lift the SP
ATB
From today’s News l like the bit below mentions AI must be good for the future?
, IQE is further demonstrating the technology's scalability, enabling a step change in volume manufacturing to satisfy an increasing demand for DFB lasers. This also ensures optical interconnect technology remains cost competitive, as network traffic scales to meet the requirements of generative AI and data intensive applications.
NHS adopted the next to useless PSA test If you listen to the CEO they cannot improve on validation or statistical significance as the data they possess for each patient has a 3D conformation genetic changes containing hundreds of data points The epi switch is unique tech compared to PSA and of course more data will evolve
Https://www.reuters.com/technology/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22/
“Merits further investigation “ very disappointing to hear those words and SNG appears to be doing nothing likewise with COPD ? Talking of which on BBC Morning Live demonstrated a device that can diagnose COPD using AI instead of a spirometer .AI seems the way forward in clinical trials and pulmonary medicine just hope SNG are embracing the new tech
Had this email this morning from Prostate Cancer UK to which I make donations .Interesting they refer research to resistance to treatments and a new delivery system to treat resistance tumours Resistance appears to be a big problem and Avacta to be very much ahead in this field of research
"Thanks to many years of research, supported by you, treatments for prostate cancer are more effective than ever.
But for some men, their prostate cancer can become resistant to treatment and start to grow again. With your help, we’re funding researchers like Professor John Callan from Ulster University to develop new treatments that overcome this resistance. "
Professor Callan and his team have found a new combination of treatments, and a unique way to deliver them, that they believe can help control prostate cancer that has come back - packaging chemotherapy drugs in microscopic bubbles.
It sounds like science fiction, but if it works, this microbubble treatment would be more targeted than existing treatments, reducing side effects and improving and extending the lives of men with prostate cancer
Http://otp.investis.com/clients/uk/oxford_biodynamics_plc/rns/regulatory-story.aspx?cid=2040&newsid=936155
No body mentioned the importance of epi switch patents which will of great interest to Big Pharma
Https://www.phosp.org/
I wonder if SNG are involved in PHOSP covid study ?
Https://hackernoon.com/why-using-artificial-intelligence-in-clinical-trials-is-becoming-the-new-normal
RM mentioned "New technologies" just hope they are embracing AI to speed up Clinical trials and reduce staff cost Paul Hudson CEO Sanofi and other Big Pharma are getting involved